about
Anaplastic lymphoma kinase-positive large B-cell lymphoma: an underrecognized aggressive lymphomaGranulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent mannerDissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.Diagnostic accuracy of a defined immunophenotypic and molecular genetic approach for peripheral T/NK-cell lymphomas. A North American PTCL study group project.The requirement for ATP hydrolysis by Saccharomyces cerevisiae Rad51 is bypassed by mating-type heterozygosity or RAD54 in high copyGauging NOTCH1 Activation in Cancer Using Immunohistochemistry.Disruption of CXCR4 enhances osteoclastogenesis and tumor growth in boneSkeletal complications of breast cancer therapiesMyeloid neoplasm demonstrating a STAT5B-RARA rearrangement and genetic alterations associated with all-trans retinoic acid resistance identified by a custom next-generation sequencing assay.Mutant Calreticulin Requires Both Its Mutant C-terminus and the Thrombopoietin Receptor for Oncogenic TransformationComplete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell LymphomaIdelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.Pediatric-type nodal follicular lymphoma: a biologically distinct lymphoma with frequent MAPK pathway mutations.The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?Case report and literature review: cardiac tamponade as a complication of pericardial extramedullary hematopoiesis.Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report.APT102, a novel adpase, cooperates with aspirin to disrupt bone metastasis in mice.Cutaneous radiation-associated angiosarcoma of the breast: poor prognosis in a rare secondary malignancy.An improved algorithm for activated protein C resistance and factor V Leiden screening.Immunohistochemical detection of hairy cell leukemia in paraffin sections using a highly effective CD103 rabbit monoclonal antibody.Incidence and clinical features of extramedullary multiple myeloma in patients who underwent stem cell transplantation.Patterns of expression of CD56 and CD117 on neoplastic plasma cells and association with genetically distinct subtypes of plasma cell myeloma.An extreme example of focal bone marrow involvement in acute myeloid leukemia.PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues.A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation.Mentoring. Volunteers bring passion to science outreach.Targetable subsets of non-Hodgkin lymphoma in Malawi define therapeutic opportunitiesSystematic sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemiaThe Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in MiceDetection of activating MAP2K1 mutations in atypical hairy cell leukemia and hairy cell leukemia variantExtramedullary Waldenström macroglobulinemiaClinicopathologic and genetic characterization of nonacute -mutated myeloid neoplasmsClinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopeniasMechanisms of Lymphoma Clearance Induced by High-Dose Alkylating AgentsRecurrent genetic HLA loss in AML relapsed after matched unrelated allogeneic hematopoietic cell transplantationDetection of the KITD816V mutation in myelodysplastic and/or myeloproliferative neoplasms and acute myeloid leukemia with myelodysplasia-related changes predicts concurrent systemic mastocytosisTargeted inhibition of CD47-SIRPα requires Fc-FcγR interactions to maximize activity in T-cell lymphomas
P50
Q21285042-FD9E736B-3403-4D91-939A-D537DAFD1B08Q24683680-5AADBBE5-2B02-4D0A-9EFE-3255D79475D6Q33752896-16EDB8A0-7396-43DE-8F7E-2587149DDB5DQ33856647-FBEE4450-D65E-4A07-A5AE-1059ECDC033AQ34324560-31D096BF-300A-466C-9B3B-6F31C446843AQ34794876-5AB0523C-831C-4C9F-BA9C-979206FD41FCQ35956822-F053A73D-A12B-49AE-84BF-7CC7ECF37E15Q36633831-A2C428FC-4238-4C2A-AC89-C3575D29B4B6Q36851451-7CE1C4A7-C04F-4B74-B386-B358A5DA0C93Q36853951-CEF92CD2-AC79-4397-AE48-D9B518CF70B4Q36914387-9F7455BB-BC74-4468-A4D2-2EF251E06BCBQ37097096-7C327854-74B9-4736-AFFE-CB09D33B0EABQ37210452-91D88717-A6E7-434E-BB35-6A9C77BE610AQ37526352-004044B8-409D-4912-9F81-2DB243023ED0Q37694721-A00A93CD-9487-4D2A-9258-538E2D2EAF8AQ38862092-66B159B0-64FC-413D-A9C9-58E8BF21CE65Q40373206-429E9363-8BA3-4059-9FBA-F5DBC4B61AA8Q41877140-65597E23-63AE-4EE7-B2A9-ADE69825CF7AQ43506077-53EB8C4D-4995-4993-8272-61FA1A77AADAQ44001540-1DF23147-B2AE-4F54-B53C-40C36971AE23Q44116169-9F16EBF9-EE94-4A16-8F8E-71CFD299D49CQ44241157-88D717A2-B4C2-484B-BB5F-2D9BAC5AB349Q45147338-36E509E2-6BCE-4546-B81E-FDC13F526E9EQ46043578-222BDBB2-6844-4267-B440-A3A620EF4621Q46947953-9947F67F-4F96-494F-A120-9D854CDBB4CFQ48163017-C10B9CCC-9084-4520-98FB-1AE2DFB4467EQ48186628-55FE234F-0BF4-4E75-AD66-EC0ECB972789Q48622155-8F06A8A7-73DE-4455-AC7B-A304ADC4050DQ62491658-7F9B8887-0B22-4488-8BBD-431815AB9C53Q62963843-CF71B767-5B0B-438E-9B28-831EEA943E05Q62963901-916E4FB2-1621-4CD0-9B7A-8DFFAA467758Q62963914-E7BC7157-E2C0-47B3-B10D-8D872B6ECD7EQ62963992-6016E1A2-2A7F-420C-B76E-D4CD0BAF2C0AQ64056959-B0380F3C-A1E0-4A0E-9A58-A1716E8EC9A4Q91164977-57BA90C4-4B0F-4B95-8C19-2902A98866C3Q91650387-3936877F-699D-4C95-89EA-9A3B0A3B9B1AQ92033372-09D8521C-FA76-411B-80AD-187AECB31071Q92381105-4E97361D-03DB-47BC-9098-224206E98FF1Q92429878-A8F4B0D0-1087-4410-A045-C14993D18BB4
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elizabeth Morgan
@ast
Elizabeth Morgan
@en
Elizabeth Morgan
@es
Elizabeth Morgan
@nl
Elizabeth Morgan
@sl
إليزابيث مورغان
@ar
type
label
Elizabeth Morgan
@ast
Elizabeth Morgan
@en
Elizabeth Morgan
@es
Elizabeth Morgan
@nl
Elizabeth Morgan
@sl
إليزابيث مورغان
@ar
prefLabel
Elizabeth Morgan
@ast
Elizabeth Morgan
@en
Elizabeth Morgan
@es
Elizabeth Morgan
@nl
Elizabeth Morgan
@sl
إليزابيث مورغان
@ar
P106
P21
P31
P496
0000-0001-5880-9337